239 related articles for article (PubMed ID: 11274933)
1. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP).
Fonarow GC; Gawlinski A; Moughrabi S; Tillisch JH
Am J Cardiol; 2001 Apr; 87(7):819-22. PubMed ID: 11274933
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Program at the University of California Los Angeles.
Fonarow GC; Gawlinski A
Am J Cardiol; 2000 Feb; 85(3A):10A-17A. PubMed ID: 10695702
[TBL] [Abstract][Full Text] [Related]
3. In-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes: the University of California-Los Angeles, Cardiovascular Hospitalization Atherosclerosis Management Program.
Fonarow GC; Gawlinski A; Watson K
Crit Pathw Cardiol; 2003 Jun; 2(2):61-70. PubMed ID: 18340322
[TBL] [Abstract][Full Text] [Related]
4. UCLA's coronary artery disease initiative begins at the hospital with medication, lifestyle interventions.
Clin Resour Manag; 2001 Jul; 2(7):109-11. PubMed ID: 11482249
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention of coronary artery disease in contemporary clinical practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
[TBL] [Abstract][Full Text] [Related]
6. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
Longenecker JC; Alfaddagh A; Zubaid M; Rashed W; Ridha M; Alenezi F; Alhamdan R; Akbar M; Bulbanat BY; Al-Suwaidi J
Int J Cardiol; 2013 Aug; 167(4):1406-11. PubMed ID: 22578736
[TBL] [Abstract][Full Text] [Related]
7. Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital.
Mitra S; Findley K; Frohnapple D; Mehta JL
Clin Cardiol; 2002 Jan; 25(1):16-8. PubMed ID: 11808833
[TBL] [Abstract][Full Text] [Related]
8. Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues.
Underwood P; Beck P
Qual Saf Health Care; 2002 Sep; 11(3):230-2. PubMed ID: 12486986
[TBL] [Abstract][Full Text] [Related]
9. The Swedish National Programme for Quality Control of Secondary Prevention of Coronary Artery Disease--results after one year.
Stagmo M; Israelsson B; Brandström H; Hedbäck B; Lingfors H; Nilsson P; Erhardt L
Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):18-24. PubMed ID: 15167202
[TBL] [Abstract][Full Text] [Related]
10. Statin and beta-blocker therapy and the initial presentation of coronary heart disease.
Go AS; Iribarren C; Chandra M; Lathon PV; Fortmann SP; Quertermous T; Hlatky MA;
Ann Intern Med; 2006 Feb; 144(4):229-38. PubMed ID: 16490908
[TBL] [Abstract][Full Text] [Related]
11. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
Zeymer U; Jünger C; Zahn R; Bauer T; Bestehorn K; Senges J; Gitt A
Curr Med Res Opin; 2011 Aug; 27(8):1563-70. PubMed ID: 21682553
[TBL] [Abstract][Full Text] [Related]
12. CAD initiative begins at the hospital with medication, lifestyle interventions.
Clin Resour Manag; 2001 Sep; 2(9):132-5, 129. PubMed ID: 11577511
[TBL] [Abstract][Full Text] [Related]
13. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
[TBL] [Abstract][Full Text] [Related]
14. [Secondary prevention of cardiovascular diseases].
Schneider CA; Erdmann E
Internist (Berl); 2004 Jun; 45 Suppl 1():S23-30. PubMed ID: 15148584
[TBL] [Abstract][Full Text] [Related]
15. Post-hospitalization management of high-risk coronary patients.
Muhlestin JB
Am J Cardiol; 2000 Mar; 85(5A):13B-20B. PubMed ID: 11076126
[TBL] [Abstract][Full Text] [Related]
16. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
[TBL] [Abstract][Full Text] [Related]
17. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
Kumbhani DJ; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Deedwania P; Grau-Sepulveda M; Schwamm LH; Bhatt DL;
Am J Med; 2015 Apr; 128(4):426.e1-9. PubMed ID: 25433302
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].
Can LH; Kayıkçıoğlu M; Yavuzgil O; Kültürsay H; Soydan I
Turk Kardiyol Dern Ars; 2010 Sep; 38(6):387-92. PubMed ID: 21200116
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular protection and prevention in patients with cardiac conditions and diabetes].
Charpentier G; Puel J; Steg PG
Presse Med; 2005 Oct; 34(18):1295-8. PubMed ID: 16269992
[TBL] [Abstract][Full Text] [Related]
20. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
